Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,443 total articles
Southwest Airlines (LUV) faces near-term earnings pressure from a sudden jump in jet fuel prices, but the stock now offers a tactical long opportunity for disciplined traders. We lay out an actionable entry at $37.50, a stop at $30.00 and a target of $52.00 tied to normalization of fuel costs and seasonal revenue reacceleration. Expect volatility; …
Block is a buy here based on accelerating banking activity inside Cash App, improving payments margins at Square, and clear paths to operational leverage. Detailed financials were not available at the time of writing, so this thesis leans on observable business trends and a clear risk-managed entry, stop, and target plan.
Sea (SE) is trading near $85 after a painful derating from last year’s highs despite record 2025 revenue of $22.9B and a stronger balance sheet. Weak sentiment and margin anxiety created an entry window. This trade targets recovery as Shopee and SeaMoney reinvest for durable share gains while Garena stabilizes.
Nurix Therapeutics is trading at $16.24 after a constructive corporate update and strong Phase 1 data for its BTK degrader bexobrutideg. With DAYBreak pivotal enrollment underway, a planned Phase 3 start by mid-2026, and a healthy cash position of $540.7M, we rate NRIX a Strong Buy. Our trade plan targets $24.00 over a 180 trading day horizon with …
JPMorgan ($JPM) is trading near $310 after a run-up into earnings week. The bank's $2B-per-year AI savings narrative, industry-leading trading franchise and conservative balance sheet set up a favorable risk/reward into the April results. We recommend a tactical long with an entry at $310.00, a stop at $295.00 and a target of $335.00 over a mid-ter…
The Trade Desk (TTD) has collapsed from its highs and now trades at a valuation more typical of a mature software business despite continued revenue growth, high gross margins, and meaningful free cash flow. Management insider buying, oversold technicals, and an attainable path to margin recovery make TTD a high-conviction, deep-value long for pati…
Nano Labs is trading at a fraction of prior highs with a market cap under $71M, a P/E of 3.7 and PB of 0.63. Management has cut costs aggressively and built a sizable BNB reserve; CEO buying and improving technicals add to the bull case. This trade targets a recovery re-rating over the next 180 trading days while keeping a tight damage-limiting sto…
<p>Meta's Muse Spark launch on 04/08/2026 is more than PR — it is the first clear sign that the company's AI investment is transitioning from R&D to product leverage across its Family of Apps. The stock has already reacted, and the setup now offers an actionable long with defined entry, stop, and target levels tied to fundamentals and technical pos…
British American Tobacco offers a 5.1% yield, a modest valuation (PE ~13) and exposure to high-growth oral nicotine pouches and cannabis investments. That mix creates a trade setup with defined upside to the 52-week high and downside protection via a stop below recent support. This idea is a swing trade that pairs income with a catalyst-driven re-r…
Revolve is executing on a Growth-At-a-Reasonable-Price thesis: mid-single-digit top-line growth, expanding profitability, positive free cash flow and no long-term debt. At $25.74 the stock trades at ~29x earnings and 1.45x sales with a $1.84B market cap, leaving room for upside if active customers and owned-brand penetration continue to improve.
Intel's recent string of strategic wins - including a prominent role in the Terafab project - and accelerating momentum in Intel Foundry Services make a high-conviction, actionable long trade. Market validation from partners and improving technicals support a longer-term play while execution and capital intensity remain real risks. Entry $60.50, ta…
Genmab is a high-quality antibody therapeutics developer trading at $28.54 with an $18.1B market cap. Recent Phase 3 results for epcoritamab (PFS positive, OS non-significant), the acquisition of Merus' petosemtamab and a 4.99% stake from Orbis make the stock sensitive to a cluster of near-term binaries. I outline a mid-term (45 trading days) long …
Nasdaq's core marketplace and expanding fintech footprint are showing tangible organic momentum even as macro uncertainty pressures near-term volumes. The stock is trading below key moving averages, offers a 1.2% yield, generates roughly $2.0B in free cash flow and has a valuation that still leaves upside if pilots and product rollouts accelerate. …
Elemental Royalty (ELE) is a focused precious-metals royalty acquirer trading at a $1.26B market cap. The company owns uncapped royalties across producing and near-producing mines and recently monetized a Nordic unit while retaining a 1% NSR in the region. With gold price direction, an acquisitive mandate, and a lean team, ELE offers a tradeable lo…
<p>Amadeus' U.S. OTC listing has been under pressure recently, but the technical picture and a rising short burden suggest the down leg may be stabilizing. With MACD turning positive, price sitting just below key short-term averages and short interest elevated, there is a tradeable asymmetric setup: limited downside with a clear recovery path to pr…
ECARX’s acquisition of DreamSmart pushes the company deeper into in-car software and content monetization. The move can accelerate recurring revenue and OEM relationships, but it is capital-intensive and raises execution risk. We lay out a mid-term swing trade that buys the thesis while limiting downside exposure.
Oscar Health (OSCR) is a high-growth ACA marketplace insurer that has suffered a sharp share-price reset. With membership growth, 2026 guidance for $18.7-19.0B revenue and $250-450M in operating earnings, and bargain-like multiples (EV/Sales ~0.18, P/S ~0.38), the risk/reward favors a constructive long position. This trade targets a full re‑rating …
Volaris (VLRS) has the network and cost discipline of an ultra-low-cost carrier, but a renewed oil shock and recent revenue softness create a window to short the stock over the mid-term. Enter at $7.65, stop at $8.40, target $6.00 on a 45-trading-day horizon.
Helios (HLIO) has moved from distressed lows to a constructive technical and fundamental setup. With solid free cash flow, manageable leverage and improving technical momentum, the stock looks actionable on a disciplined entry. This trade idea lays out an exact entry, stop and target tied to support, moving averages and valuation context — but it a…
Broadcom just crossed an inflection point: a strategic Triad AI partnership (deal details limited publicly) materially strengthens its custom-ASIC and data-center networking moats. Valuation is rich but supported by large free cash flow, strong returns on equity, and improving technicals. This trade plan targets capitalizing on continued enterprise…
I increased my Tesla position at $342.34 because the setup combines an oversold technical base, meaningful free cash flow, low leverage and a near-term product roadmap that could reaccelerate volumes. Valuation is full, so this is a tactical, growth-with-drawdown trade sized for conviction but capped for risk.
Coca-Cola HBC (CCHGY) looks buyable around $58.45. The company mixes predictable beverage volume recovery across Europe with margin resilience and a dividend yield near 1.9%. With a market cap of roughly $21.3B, a P/E around 20 and constructive technicals, this is a medium-risk, long-term trade aimed at recapturing the 52-week high while collecting…
Microsoft looks like a candidate where the selloff is driven by macro uncertainty rather than company-specific deterioration. For traders willing to accept medium risk, a controlled long with a clear stop and a mid-term horizon capitalizes on likely mean reversion as fundamentals and AI-driven revenue durability reassert themselves.
Teradyne has quietly moved from a cyclical semiconductor-test play to a diversified supplier of AI infrastructure and automation. Strong AI-related demand, expanding robotics revenue, healthy cash flow and low leverage support a long-biased trade. Valuation is rich vs. history but justified by rapid revenue/margin expansion; trade with a clear stop…
TSMC is the dominant foundry behind the AI compute boom. With a $1.88 trillion market cap, strong technical momentum, and hyperscaler capex forecasts supporting demand, a disciplined long trade into weakness makes sense. Entry at $364, stop $345, target $420 over a 180-trading-day horizon balances upside from continued AI investment against valuati…
